Trials / Conditions / Recurrent Esophageal Squamous Cell Carcinoma
Recurrent Esophageal Squamous Cell Carcinoma
4 registered clinical trials studyying Recurrent Esophageal Squamous Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected NCT06265285 | Mayo Clinic | Phase 2 |
| Completed | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer NCT01469598 | Samsung Medical Center | Phase 2 |
| Active Not Recruiting | Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal NCT01142388 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gast NCT01178944 | Roswell Park Cancer Institute | Phase 2 |